AMAG Pharma (AMAG) Posts Q1 Loss of $1.06, Sales Miss Views

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/1/2026

1. INTC
2. AMZN
3. RDDT
4. PINS
5. COIN
6. FSLR
7. SYK
8. DASH
9. FND
10. GILD

Go back to AMAG Pharma (AMAG) Posts Q1 Loss of $1.06, Sales Miss Views

AMAG Pharmaceuticals Announces First Quarter 2017 Financial Results and Provides Corporate Update

May 2, 2017 7:01 AM EDT

First quarter 2017 GAAP revenue increased 28%

Company announced positive Feraheme Phase 3 data

Conference call scheduled for 8:00 a.m. ET today

WALTHAM, Mass., May 02, 2017 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today reported unaudited consolidated financial results for the quarter ended March 31, 2017. Total GAAP revenue for the first quarter of 2017 increased to $139.5 million, approximately 28% higher than the same period last year. This increase was primarily driven by growth in net sales of Makena® (hydroxyprogesterone caproate injection). The company reported an... More